Literature DB >> 23247981

The positive lymph node ratio predicts long-term survival in patients with operable thoracic esophageal squamous cell carcinoma in China.

Xue Hou1, Jin-Chang Wei, Ying Xu, Rong-Zhen Luo, Jian-Hua Fu, Lan-Jun Zhang, Peng Lin, Hao-Xian Yang.   

Abstract

BACKGROUND: Controversy exists concerning the optimal cutoff points for the positive lymph node ratio (PLNR) to predict overall survival. We aim to propose reasonable PLNR categories for the discrimination of the survival difference between groups.
METHODS: We used data from two centers to establish a training (n = 1006) and a validation (n = 783) cohort. All of the patients underwent curative surgical treatment. Martingale residuals from a Cox proportional hazards regression model were used to determine the optimal cutoff points for PLNR to predict overall survival. The survival rate was calculated using the Kaplan-Meier method, and a log-rank test was used to assess the survival differences between groups. The results obtained from the training cohort were tested with the validation cohort at each step.
RESULTS: We classified the patients into four revised nodal categories: R-pN0 (PLNR = 0), R-pN1 (0< PLNR ≤0.1), R-pN2 (0.1< PLNR ≤0.3), and R-pN3 (PLNR >0.3). Subgroup analysis for the pT2 and pT3 cases showed that the survival differences could be well discriminated between groups based on PLNR in both the training cohort and validation cohort. When we modified the current staging system using revised nodal categories (based on PLNR) instead of the AJCC nodal categories, the survival rate could also be easily distinguished between patients in different stages in both cohorts of patients.
CONCLUSIONS: The survival rate of ESCC can be discriminated between four groups: PLNR = 0, 0< PLNR ≤0.1, 0.1< PLNR ≤0.3, and PLNR >0.3. Further studies are required to confirm these results.

Entities:  

Mesh:

Year:  2012        PMID: 23247981     DOI: 10.1245/s10434-012-2794-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  15 in total

1.  Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.

Authors:  Guoping Xu; Ming Jin; Yingjie Shao; Yuan Chen; Zhonghua Ning
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

2.  Lymph node ratio-based staging system for esophageal squamous cell carcinoma.

Authors:  Shao-Bin Chen; Hong-Rui Weng; Geng Wang; Xiao-Fang Zou; Di-Tian Liu; Yu-Ping Chen; Hao Zhang
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

3.  The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.

Authors:  Norio Yukawa; Toru Aoyama; Hiroshi Tamagawa; Ayako Tamagawa; Yosuke Atsumi; Shinnosuke Kawahara; Yukio Maezawa; Kazuki Kano; Masaaki Murakawa; Keisuke Kazama; Masakatsu Numata; Takashi Oshima; Munetaka Masuda; Yasushi Rino
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

4.  Implication of visceral obesity in patients with esophageal squamous cell carcinoma.

Authors:  Akihiko Okamura; Masayuki Watanabe; Kotaro Yamashita; Masami Yuda; Masaru Hayami; Yu Imamura; Shinji Mine
Journal:  Langenbecks Arch Surg       Date:  2017-12-02       Impact factor: 3.445

5.  SIRT1 expression is associated with lymphangiogenesis, lymphovascular invasion and prognosis in pN0 esophageal squamous cell carcinoma.

Authors:  Guan-Qing Chen; Hui Tian; Wei-Ming Yue; Lin Li; Shu-Hai Li; Lei Qi; Cun Gao; Li-Bo Si; Ming Lu; Fei Feng
Journal:  Cell Biosci       Date:  2014-08-26       Impact factor: 7.133

6.  Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.

Authors:  Ali Ayhan; Nazlı Topfedaisi Ozkan; Mustafa Erkan Sarı; Husnu Celik; Murat Dede; Özgür Akbayır; Kemal Güngördük; Hanifi Şahin; Ali Haberal; Tayfun Güngör; Macit Arvas; Mehmet Mutlu Meydanlı
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

7.  The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.

Authors:  Vignesh Raman; Oliver K Jawitz; Norma E Farrow; Soraya L Voigt; Kristen E Rhodin; Chi-Fu J Yang; Megan C Turner; Thomas A D'Amico; David H Harpole; Betty C Tong
Journal:  Ann Surg       Date:  2022-03-01       Impact factor: 13.787

8.  Prognostic analysis of esophageal cancer in elderly patients: metastatic lymph node ratio versus 2010 AJCC classification by lymph nodes.

Authors:  Ji-Feng Feng; Ying Huang; Lu Chen; Qiang Zhao
Journal:  World J Surg Oncol       Date:  2013-07-18       Impact factor: 2.754

9.  Metastatic lymph node ratio demonstrates better prognostic stratification than pN staging in patients with esophageal squamous cell carcinoma after esophagectomy.

Authors:  Hongdian Zhang; Huagang Liang; Yongyin Gao; Xiaobin Shang; Lei Gong; Zhao Ma; Ke Sun; Peng Tang; Zhentao Yu
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

10.  Metastatic to negative lymph node ratio demonstrates significant prognostic value in patients with esophageal squamous cell carcinoma after esophagectomy.

Authors:  Xiao-Feng Duan; Peng Tang; Xiao-Bin Shang; Hong-Jing Jiang; Zhen-Tao Yu
Journal:  Oncotarget       Date:  2017-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.